Literature DB >> 9852531

Inhibition of cell proliferation in head and neck squamous cell carcinoma cell lines with antisense cyclin D1.

M B Wang1, K R Billings, N Venkatesan, F L Hall, E S Srivatsan.   

Abstract

Cyclin D1 and cyclin G are essential regulatory factors in the progression of the cell cycle from G0 through G1 and S phase. Aberrations in expression of these cyclins may lead to dysregulated cellular proliferation that could result in neoplasia. Amplification and overexpression of cyclin D1 have been observed in many human cancers, whereas cyclin G is a new cyclin recently described in osteosarcoma cells. This study was performed to determine whether these cyclins were amplified in head and neck squamous cell carcinoma (HNSCC) tumors. Polymerase chain reaction of DNA extracted from 22 HNSCC primary tumors and three HNSCC cell lines did not reveal amplification of cyclin D1 in any of the tumor samples. Southern blot analysis identified amplification of cyclin D1 in a single tumor. Amplification of cyclin G was not observed in any of the tumors by Southern blot hybridization with a cyclin G probe. HNSCC cell lines transfected with antisense cyclin D1 were tested for cell proliferation by the incorporation of 3H-thymidine into cells grown in serum-free media. By 72 hours of incubation, there was a greater than 30% reduction in proliferation of cells transfected with antisense cyclin D1 as compared with non-transfected control cells. The results indicate that cyclin D1 may play an important role in the growth and proliferation of HNSCC cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852531     DOI: 10.1016/S0194-5998(98)70017-8

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  5 in total

1.  Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover.

Authors:  S Lin; W Wang; G M Wilson; X Yang; G Brewer; N J Holbrook; M Gorospe
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells.

Authors:  Xin Huang; Susanne M Gollin; Siva Raja; Tony E Godfrey
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

3.  Specific down-regulation of an engineered human cyclin D1 promoter by a novel DNA-binding ligand in intact cells.

Authors:  M E Laurance; D B Starr; E F Michelotti; E Cheung; C Gonzalez; A W Tam; J Deikman; C A Edwards; A J Bardwell
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

4.  Growth inhibition of head and neck squamous cell carcinoma cells by sgRNA targeting the cyclin D1 mRNA based on TRUE gene silencing.

Authors:  Satoshi Iizuka; Nobuhiko Oridate; Masayuki Nashimoto; Satoshi Fukuda; Masato Tamura
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

5.  Cyclin D1 antisense oligonucleotide inhibits cell growth stimulated by epidermal growth factor and induces apoptosis of gastric cancer cells.

Authors:  Y Saikawa; T Kubota; Y Otani; M Kitajima; I M Modlin
Journal:  Jpn J Cancer Res       Date:  2001-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.